Spots Global Cancer Trial Database for Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Official Title: Effect of Ocoxin®-Viusid® Nutritional Supplement on the Quality of Life of Patients With Advanced Stomach Cancer and Esophagogastric Junction. Phase II Clinical Trial.
Study ID: NCT03549494
Interventions
Study Description
Brief Summary: Our main objective is to evaluate the effect of Ocoxin-Viusid on the quality of life of patients with advanced stomach cancer and esophagogastric junction. The Ocoxin-Viusid nutritional supplement is expected to improve quality of life and tolerance to treatment with Chemotherapy.
Detailed Description: * To evaluate the effect of Ocoxin-Viusid on the quality of life of patients * To evaluate the toxicity of Ocoxin-Viusid in combination with chemotherapy (QT). * To assess the influence of Ocoxin-Viusid on tolerance to treatment with chemotherapy. * Identify the changes that occur in the nutritional status of patients receiving the supplement.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Institute of Oncology and Radiobiology (INOR), Havana, La Habana, Cuba
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
